Lime Chemicals Limited has issued a postal ballot notice dated 20th March, 2026, seeking shareholder approval for two significant corporate actions. The company's Board of Directors approved these proposals on 13th March, 2026, which now require member consent through the postal ballot process.

Registered Office Relocation

The primary proposal involves shifting the company's registered office within Maharashtra state. The relocation details are structured as follows:

The Board has cited administrative convenience, operational efficiency, and ease of coordination with statutory and regulatory authorities as key reasons for this shift. The company emphasizes that this relocation will not affect its business activities, member rights, or impact employees and creditors.

Director Appointment

The second proposal seeks to regularize the appointment of Mr. Rahim Narsingdani as an Additional Non-Executive Independent Director. The appointment details include:

Mr. Narsingdani brings expertise in Information Technology, including IT infrastructure management, system administration, network security, and software solutions implementation. The appointment was recommended by the Nomination and Remuneration Committee and requires shareholder approval within three months as per SEBI Listing Regulations.

E-Voting Process and Timeline

The company has engaged National Securities Depository Limited (NSDL) to facilitate remote e-voting. HD and Associates, Practicing Company Secretary, has been appointed as the Scrutinizer to ensure a fair and transparent voting process.

Regulatory Compliance and Publication

In compliance with Regulation 47 of SEBI Listing Regulations, the company has published newspaper advertisements of the postal ballot notice on 23rd March, 2026. The advertisements were published in "The Free Press Journal" (English Language) and "Navshakti" (Marathi Language) newspapers to ensure broad accessibility to shareholders.

The postal ballot notice is being sent only through electronic mode to members whose email addresses are registered with the company or depositories, in accordance with MCA Circular No. 09/2023 dated September 25, 2023.

Corporate Governance Compliance

Both resolutions demonstrate the company's commitment to regulatory compliance and corporate governance standards. The registered office shift requires Regional Director approval under Sections 12 and 13 of the Companies Act, 2013, while the director appointment aligns with SEBI Listing Regulations requirements for independent director appointments.

The company has made arrangements with Bigshare Services Pvt. Ltd, its Registrar and Share Transfer Agent, to enable members to register their email addresses for receiving the notice. The results will be communicated to stock exchanges and made available on the company's website at www.limechem.com and NSDL's platform, ensuring transparency in the voting process.

Lime Chemicals Limited's board of directors approved the shifting of the company's registered office during their meeting held on March 13, 2025, as disclosed in their official communication to BSE Limited under Regulation 30 of the SEBI Listing Regulations.

Board Meeting Details

The board meeting commenced at 03:45 P.M. and concluded at 04:20 P.M. on Friday, March 13, 2025. The decision was taken in accordance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Registered Office Relocation Approved

The board approved shifting the company's registered office from its current location to a new address within Mumbai, representing a jurisdictional change while remaining in the same state of Maharashtra.

Regulatory Compliance

The relocation involves a change from the jurisdiction of ROC Mumbai II to ROC Mumbai I within the same state of Maharashtra. This corporate restructuring decision is subject to approval of members in the ensuing General Meeting, as required under applicable regulations.

The company has made the necessary disclosure to BSE Limited, where its shares are listed under scrip code 507759, ensuring compliance with listing obligations and maintaining transparency with stakeholders regarding this operational change.